The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains to the 30% of strains that were sensitive to the bnAb. This ...
Mar 17, 2021
0
25
A study from a Massachusetts General Hospital (MGH) research team has identified the specific function of a protein found in HIV and related viruses that appears to slow down viral spread in the earliest stages of infection. ...
Jan 10, 2019
0
72
(Medical Xpress) -- Research at Victoria University is targeting new drugs to fight drug-resistant and other forms of tuberculosis (TB).
Aug 30, 2011
0
0
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...
Sep 20, 2017
0
51
Countries must halt the rise of AIDS drug resistance to prevent a swell in new infections and deaths and spiralling treatment cost, the UN's health agency warned Thursday.
Jul 20, 2017
0
1
Researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Simon Fraser University (SFU), in partnership with University of British Columbia (UBC) and Western University, have developed a novel way for dating "hibernating" ...
Sep 5, 2018
0
17
Although combinatorial antiretroviral therapies (cARTs) have dramatically reduced the occurrence of HIV-1-related dementia and encephalitis, recent studies have shown a rise in the number of HIV-positive individuals who will ...
May 9, 2016
0
14
Most HIV epidemics are still dominated by the first strain that entered a particular population. New research published in PLOS Computational Biology offers an explanation of why the global mixing of HIV variants is so slow.
Feb 5, 2015
0
10
A team of NIH scientists has developed a new tool to identify broadly neutralizing antibodies (bNAbs) capable of preventing infection by the majority of HIV strains found around the globe, an advance that could help speed ...
May 9, 2013
0
0
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...
Sep 10, 2018
0
14
